BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36722414)

  • 1. Proton-to-photon comparative treatment planning guidelines for the Australian context.
    Penfold SN; Dell'Oro M; Gorayski P; Hwang E; Le H; Penfold M; Sykes J; Vu H; Yeo A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):320-328. PubMed ID: 36722414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proton versus photon treatment planning for the Medicare Medical Treatment Overseas Program: The Royal Adelaide Hospital experience.
    Hu Y; Dalfsen R; Penfold SN; Gorayski P; Tee HC; Penniment M; Le H
    J Med Imaging Radiat Oncol; 2020 Oct; 64(5):682-688. PubMed ID: 32243727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
    Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of clinician opinions on the role of proton beam therapy in Australia and New Zealand.
    McNeil N; Gorayski P; Le H; Penniment M; Hanna GG; Thwaites D; Roos D; Kenny LM; Ahern V
    J Med Imaging Radiat Oncol; 2020 Oct; 64(5):689-696. PubMed ID: 32924305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
    Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
    Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a comparative photon-proton planning service in Victoria: the experience at Peter MacCallum Cancer Centre.
    Gunewardena R; Hall L; Li M; Drum G; Le D; Nigro E; Houlder B; Phillips C; Wheeler G; Wiltshire K; Kron T; Yeo A
    J Med Radiat Sci; 2024 Apr; 71 Suppl 2(Suppl 2):82-89. PubMed ID: 38305062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Photon Treatment Back-up Workflow at a High-Volume Proton Center: Safety, Quality, and Patient Considerations.
    Laughlin BS; Anderson JD; Gagneur JD; Chungbin SJ; Bues M; Hobbis D; Fatyga M; Korte SM; Carroll SE; Vora S; Sio TT; Wong WW; Keole SR; Rong Y
    Pract Radiat Oncol; 2022; 12(5):e453-e459. PubMed ID: 35272078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
    Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
    Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton beam therapy for locally advanced lung cancer: A review.
    Schild SE; Rule WG; Ashman JB; Vora SA; Keole S; Anand A; Liu W; Bues M
    World J Clin Oncol; 2014 Oct; 5(4):568-75. PubMed ID: 25302161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
    Liu SW; Li JM; Chang JY; Yu JM; Chen Q; Jiang QA; Mu XK; Zhao MH; Tian Y; Wei QL
    J Xray Sci Technol; 2010; 18(4):443-50. PubMed ID: 21045280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.
    Friedrich C; Boekhoff S; Bischoff M; Beckhaus J; Sowithayasakul P; Calaminus G; Eveslage M; Valentini C; Bison B; Harrabi SB; Krause M; Timmermann B; Müller HL
    Front Oncol; 2023; 13():1180993. PubMed ID: 37965466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
    Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
    J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton therapy in the clinic.
    DeLaney TF
    Front Radiat Ther Oncol; 2011; 43():465-485. PubMed ID: 21625169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies.
    Kahan J; Martinez C; Tsien C
    Curr Treat Options Oncol; 2023 Aug; 24(8):988-1003. PubMed ID: 37212933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-comparativeness of proton versus photon therapy.
    Verma V; Shah C; Rwigema JC; Solberg T; Zhu X; Simone CB
    Chin Clin Oncol; 2016 Aug; 5(4):56. PubMed ID: 27506804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
    Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW
    Clin Genitourin Cancer; 2021 Jun; 19(3):255-266.e7. PubMed ID: 32972877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
    Buchsbaum JC; McDonald MW; Johnstone PA; Hoene T; Mendonca M; Cheng CW; Das IJ; McMullen KP; Wolanski MR
    Radiat Oncol; 2014 Jan; 9():2. PubMed ID: 24383792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.